Journal article

The pathogenesis of transfusion-related acute lung injury and how to avoid this serious adverse reaction of transfusion


Authors listSachs, Ulrich J. H.

Publication year2007

Pages273-282

JournalTransfusion and Apheresis Science

Volume number37

Issue number3

ISSN1473-0502

DOI Linkhttps://doi.org/10.1016/j.transci.2007.02.005

PublisherElsevier


Abstract
Transfusion-related acute lung injury (TRALI) is a serious, life-threatening complication of blood transfusion. Available evidence strongly suggests that leukocyte antibodies present in donor plasma are the predominant mechanism in TRALI. These antibodies lead to recipient neutrophil activation, with activated neutrophils inducing endothelial and alveolar damage in the lungs. These mechanisms are discussed in detail as are the alternative mechanisms that have been proposed. Preventive strategies that may help to reduce TRALI are presented. (C) 2007 Elsevier Ltd. All rights reserved.



Citation Styles

Harvard Citation styleSachs, U. (2007) The pathogenesis of transfusion-related acute lung injury and how to avoid this serious adverse reaction of transfusion, Transfusion and Apheresis Science, 37(3), pp. 273-282. https://doi.org/10.1016/j.transci.2007.02.005

APA Citation styleSachs, U. (2007). The pathogenesis of transfusion-related acute lung injury and how to avoid this serious adverse reaction of transfusion. Transfusion and Apheresis Science. 37(3), 273-282. https://doi.org/10.1016/j.transci.2007.02.005



Keywords


ANIMAL-MODELCD40 LIGANDCLASS-II ANTIBODIESLEUKOCYTE ADHESIONL-SELECTINNEUTROPHIL FUNCTIONSPULMONARY MICROCIRCULATIONTRALI

Last updated on 2025-02-04 at 03:40